Sunshine Heart to Present at Upcoming Investor Conferences

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sunshine Heart to Present at Upcoming Investor Conferences

EDEN PRAIRIE, Minn., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq: SSH ) announced today that the company is scheduled to present a corporate update at the following upcoming investor conferences for the balance of 2014:

  • 2014 Credit Suisse Healthcare Conference

Presentation: Wednesday, November 12, 2014 at 4:00 PM MST at The Arizona Biltmore in Phoenix, Arizona. Breakout session to immediately follow presentation at 4:30 PM MST

Presenting: Jeff Mathiesen, Chief Financial Officer

  • 2014 Canaccord Genuity Medical Technology & Diagnostics Forum

Presentation: Thursday, November 20, 2014 at 1:00 PM EST at The Westin Grand Central in New York, New York

Presenting: Brian Brown, Senior Vice President of Operations and Technology

  • Piper Jaffray 26 th Annual Healthcare Conference

Presentation: Wednesday, December 3, 2014 at 4:00 PM EST at The New York Palace in New York, New York

Presenting: Dave Rosa, Chief Executive Officer

  • Oppenheimer 25 th Annual Healthcare Conference

Presentation: Wednesday, December 10, 2014, at 3:55 PM EST at The Crowne Plaza Hotel in New York, New York

Presenting: Dave Rosa, Chief Executive Officer

About the C-Pulse ®  Heart Assist System

The C-Pulse Heart Assist System, or C-Pulse System, an investigational device in the United States, Canada and countries that do not recognize the CE mark approval, utilizes the scientific principles of intra-aortic balloon counterpulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. Combined, these potential benefits may help sustain the patient's current condition or, in some cases, reverse the heart failure process, thereby potentially preventing the need for later-stage heart failure devices, such as left ventricular assist devices (LVADs), artificial hearts or transplants. It may also provide relief from the symptoms of Class III and ambulatory Class IV heart failure and improve quality of life and cardiac function. Based on the results from our feasibility study, we also believe that some patients treated with our C-Pulse System will be able to stop using the device due to sustained improvement in their conditions as a result of the therapy.

Caution: Investigational device, limited by Federal (or United States) Law to Investigational use.

About Sunshine ®  Heart

Sunshine Heart, Inc. (Nasdaq: SSH ) is an early-stage medical device company focused on developing, manufacturing and commercializing the C-Pulse System for treatment of Class III and ambulatory Class IV heart failure. Sunshine Heart has completed an approved U.S. Food and Drug Administration (FDA) feasibility clinical study of the C-Pulse System and presented the results in November 2011. In March 2012, the FDA notified the Company that it could move forward with an investigational device exemption (IDE) application. Sunshine Heart received unconditional approval from the FDA in November 2012 to initiate its pivotal study. In July 2012, Sunshine Heart received CE Mark approval for its C-Pulse System in Europe. Sunshine Heart is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland. The Company has been listed on the NASDAQ Capital Market since February 2012.

Forward-Looking Statements

Certain statements in this release are forward-looking statements that are based on management's beliefs, assumptions, expectations, and information currently available to management. All statements that address future operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements, including, without limitation, our expectations with respect to future clinical study activities and results including patient enrollment in studies. These forward-looking statements are subject to numerous risks and uncertainties, including, without limitation, the possibility that our clinical studies do not meet their enrollment goals, meet their endpoints or otherwise fail, that regulatory authorities do not accept our application or approve the marketing of the C-Pulse System, the possibility that we may be unable to raise the funds necessary for the development and commercialization of our products, that we may not be able to commercialize our products successfully in the EU and the other risk factors described under the caption "Risk Factors" and elsewhere in our filings with the Securities and Exchange Commission. You should not place undue reliance on forward-looking statements because they speak only as of the date when made and may turn out to be inaccurate. We do not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

Investor: Candice Knoll Blueprint Life Science Group T: +1-415-375-3340 Ext. 105 Jeff Mathiesen Chief Financial Officer Sunshine Heart, Inc. T: +1-952-345-4200 Media: David Schull Russo Partners T: +1-212-845-4271 Andreas Marathis Russo Partners T: +1-212-845-4235

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Circuit Adds Gabe Klein as Microtransit Expansion Adviser

Updated Category News Views 29

Municipal mobility is a slow, political grind, not a shiny-app contest, and Circuit’s decision to add Gabe Klein to its board looks aimed squarely at that reality. The all-electric microtransit operator has brought aboard somebody who has worked inside the machinery of city government, federal transportation policy, electrification, venture investing, and transportation...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 256

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 5

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 14

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
COPD Support Program Targets a Costly Care Gap Today

Updated Category News Views 129

Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 91

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 51

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 157

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 265

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Ampace Fire Test Gives Data Centers Useful Evidence

Updated Category News Views 134

Battery cabinets are becoming the awkward guest in the AI data-center boom: absolutely necessary, expensive to install, and nobody wants to discover their failure behavior during a real emergency. Ampace’s newly presented PU100 large-scale fire-test results deserve attention for that reason. This is not a magic safety stamp, and the company says the findings apply only...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Digital Twin Advancements in Aerospace and Defense

Updated Category News Views 435

Innovations in Digital Twin Technology for Aerospace and Defense In the fast-evolving world of technology, digital twins have emerged as a transformative asset, especially in the Aerospace and Defense sectors. Recently, the Digital Twin Consortium (DTC) has published an insightful whitepaper titled Aerospace-Defense: Digital Twin Research and Technology Gap Analysis. This...

Continue Reading
Arlo Technologies to Showcase Innovations at Upcoming Conference

Updated Category News Views 126

Arlo Technologies to Present at Piper Sandler Growth Frontiers Conference Arlo Technologies, Inc. (NYSE: ARLO), a top contender in the smart home security landscape, is gearing up to showcase its latest achievements at the Piper Sandler Growth Frontiers Conference. This esteemed event highlights innovative companies leading the way in technology, and Arlo is set to make a...

Continue Reading
Plug's Innovative Trade Desk Revolutionizes EV Market Dynamics

Updated Category News Views 833

Plug's Groundbreaking Initiatives in the Electric Vehicle Sector With a substantial seed funding of $6.7 million, Plug is making significant waves in the electric vehicle (EV) market by launching its pioneering Trade Desk. This service is tailored exclusively for EVs, setting a new precedent in the automotive industry, as it allows dealerships to assess, price, and...

Continue Reading
Exciting Winter and Spring Events at Long Island Aquarium

Updated Category News Views 215

Exciting Upcoming Events at Long Island Aquarium The Long Island Aquarium is thrilled to share its lineup of engaging events for winter and spring. Visitors can expect a variety of experiences designed to entertain the whole family. Whether you're a local resident or just visiting, there's something for everyone at this spectacular underwater haven. Culinary Delights...

Continue Reading
Bakkt Holdings, Inc. Announces Third Quarter Earnings Call

Updated Category News Views 91

Bakkt Holdings, Inc. Sets Conference Call for Q3 Earnings Bakkt Holdings, Inc. (NYSE: BKKT) is making waves as it prepares to discuss its financial results for the third quarter of 2024. The company has scheduled the earnings announcement for a date soon approaching, promising insights that will interest investors and analysts alike. Details of the Earnings Call The...

Continue Reading